文献速递创伤与烧伤重症综合管理与镇静镇痛

创伤幸存者筛查工具(ITSS)对伤后6个月慢性痛苦的预测:临床意义与未来方向

Six-month follow-up of the injured trauma survivor screen: Clinical implications and future directions.
PubMed 文献 · J Trauma Acute Care Surg · 2018-01-01
一句话结论9条目ITSS约5分钟完成,cut score 2时预测伤后6个月PTSD灵敏度85.42%、特异度67.35%,联合PTSD检查表可提高特异度至81.63%。

本研究在I级创伤中心入院时收集基线资料,伤后平均6.5个月随访,用ROC曲线分析ITSS对慢性PTSD和抑郁的预测能力。ITSS PTSD量表cut score 2时灵敏度85.42%、特异度67.35%、NPV 91.9%、PPV 51.4%;联合基线PTSD检查表(DSM-5)的联合风险组灵敏度72.92%、特异度81.63%、NPV 88.2%、PPV 61.6%。ITSS抑郁量表cut score 2时灵敏度72.50%、特异度70.29%、NPV 91.1%、PPV 37.9%。作者认为9条目ITSS是稳定的筛查工具,联合评估可提高特异度,并为美国外科医师学会创伤委员会关于创伤中心PTSD和抑郁筛查的建议提供依据。

要点

  • ITSS PTSD量表cut score 2预测伤后6个月PTSD:灵敏度85.42%、特异度67.35%、NPV 91.9%、PPV 51.4%。
  • 基线ITSS联合PTSD检查表(DSM-5)的联合风险组:灵敏度72.92%、特异度81.63%、NPV 88.2%、PPV 61.6%,特异度较单用ITSS提高。
  • ITSS抑郁量表cut score 2预测伤后6个月抑郁:灵敏度72.50%、特异度70.29%、NPV 91.1%、PPV 37.9%。
  • 9条目ITSS约5分钟完成,可在I级创伤中心入院后用于预测伤后6个月PTSD和/或抑郁风险。
  • 联合风险组数据提示由心理师进行症状评估可提高特异度,为美国外科医师学会创伤委员会关于创伤中心PTSD和抑郁筛查的建议提供依据。

适用人群与场景

  • 因创伤入住I级创伤中心的患者,基线在初次住院期间采集,随访在伤后平均6.5个月进行。

诊断标准与关键阈值

  • ITSS PTSD量表cut score 2用于预测伤后6个月PTSD。
  • ITSS抑郁量表cut score 2用于预测伤后6个月抑郁。
  • 联合PTSD风险组定义为基线ITSS风险阳性且PTSD检查表(DSM-5)风险阳性。

研究设计与关键结果

  • 研究类型为预后研究,证据等级III;患者在I级创伤中心入院后入组,基线在初次住院期间采集,随访平均6.5个月。
  • ITSS PTSD量表cut score 2:灵敏度85.42%、特异度67.35%、NPV 91.9%、PPV 51.4%。
  • 联合PTSD风险组(基线ITSS风险阳性且PTSD检查表DSM-5风险阳性):灵敏度72.92%、特异度81.63%、NPV 88.2%、PPV 61.6%。
  • ITSS抑郁量表cut score 2:灵敏度72.50%、特异度70.29%、NPV 91.1%、PPV 37.9%。
  • ROC曲线分析控制了参与者在伤后接受心理健康干预以及经历额外潜在心理创伤事件的情况。

证据类型、等级与局限

  • 预后研究,证据等级III。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 9条目ITSS约5分钟完成,可在I级创伤中心入院后用于筛查伤后6个月PTSD和/或抑郁高风险患者。
  • 联合风险组数据提示由心理师进行症状评估可提高特异度,为美国外科医师学会创伤委员会关于创伤中心PTSD和抑郁筛查的建议提供依据。

指南或共识出处

  • 美国外科医师学会创伤委员会关于创伤中心PTSD和抑郁筛查的建议。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The injured trauma survivor screen (ITSS) has been shown to predict posttraumatic stress disorder (PTSD) and depression risk at 1 month after traumatic injury. This study explored the ability of the ITSS to predict chronic distress after injury, as well as the impact of combining the ITSS with an additional screening measure.

METHODS: Patients were enrolled following admission to a Level I trauma center. Baseline measurements were collected during initial hospitalization, and follow-up measures were collected an average of 6.5 months after injury. Receiver operating characteristic (ROC) curve analyses were run to determine predictive accuracy, controlling for participants who had mental health intervention and for those who experienced additional potentially psychologically traumatic events since their injury event.

RESULTS: Utilizing a cut score of 2, the ITSS PTSD scale had a sensitivity of 85.42%, specificity of 67.35%, negative predictive value (NPV) of 91.9% and positive predictive value (PPV) of 51.4%. The combined PTSD risk group (risk positive on the baseline ITSS and the PTSD checklist for the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition) had a sensitivity of 72.92%, specificity of 81.63%, NPV of 88.2%, and PPV of 61.6%. Also using a cut score of 2, the ITSS Depression Scale had a sensitivity of 72.50%, specificity of 70.29%, NPV of 91.1%, and PPV of 37.9%.

CONCLUSION: The nine-item ITSS, which takes approximately 5 minutes to administer, is a stable screening tool for predicting those most at risk for PTSD and/or depression 6 months after admission to a Level I trauma center following traumatic injury. The combined PTSD risk group data provide evidence that symptom evaluation by a psychologist can improve specificity. These results further inform the recommendation of the American College of Surgeons Committee on Trauma regarding PTSD and depression screening in trauma centers.

LEVEL OF EVIDENCE: Prognostic study, level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Hunt JC, Chesney SA, Brasel K, et al. Six-month follow-up of the injured trauma survivor screen: Clinical implications and future directions. J Trauma Acute Care Surg. 2018. PMID: 29672441. doi:10.1097/TA.0000000000001944

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。